|Items||Size （2mg）||Size（5mg X 2）|
|Particle size||2 μm||2 μm|
|Coupled amount of protein||1000 pmol (49 μg) Nucleocapsid protein/mg beads||1000 pmol (49 μg) Nucleocapsid protein/mg beads|
|Capacity||>130 pmol (20 μg) Anti-Nucleocapsid antibody/mg beads||>130 pmol (20 μg) Anti-Nucleocapsid antibody/mg beads|
|Formulation||PBS, pH7.4, with 10% Trehalose||PBS, pH7.4, with 10% Trehalose|
|Reconstitution||2 mL ultrapure water (1 mg beads / mL)||Reconstitute 5 mg / bottle Beads with 5 mL ultrapure water (1 mg beads / mL)|
|Concentration||1 mg beads / mL||1 mg beads / mL|
Upon receipt, please store the Beads at -20℃ for 1 year in lyophilized state.
Please avoid more than 3 freeze-thaw cycles. Immediate use after reconstitution is highly recommended.
a) Reconstitute the Beads following the CoA, wash the Beads and suspended to a certain concentration by adding assay Buffer.
b) Add your antibody to the beads, incubation and wash the beads.
Immobilized 49 μg SARS-CoV-2 Nucleocapsid protein to 1 mg Beads can bind the Anti-SARS-CoV-2 Nucleocapsid Antibody with an EC50 of 0.6712 μg/mL (QC tested).
ACROBiosystems has developed a series of critical reagents for COVID-19 vaccine development and evaluation,including proteins, antibodies and kits. These featured products are suitable for IgG/M antibody titer detection, neutralizing antibody titer detection and antigen titer detection.
High quality SARS-CoV-2 S protein, S1 protein and human ACE2 protein based on the human cell expression platform of HEK293.
ACROBiosystems has developed a serial of high-quality antigen and antibody reagents, including super stable trimeric S protein, S RBD, S1, S2, N proteins mainly expressed by HEK 293 and paired antibodies with outstanding sensitivity verified by inactivated virus samples.
ACROBiosystems has developed a series of kit products using its high-quality SARS-CoV-2 antigen proteins to improve the efficiency of anti-SARS-CoV-2 drugs and vaccines development.
This web search service is supported by Google Inc.